Immune and gene study in mesothelioma
Part of Cancer, Lungs & breathing clinical trials.
This study is looking at the immune system and genes in mesothelioma tumors. It aims to learn more about how the body reacts to the cancer, which may help in finding better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mesothelioma of the pleura (lining of the lung) or peritoneum (lining of the belly).
- You are 18 years old or older.
- You are having or have had surgery, and both a biopsy (small sample) and the surgical tissue are available for testing.
- A pathologist (a tissue doctor) has confirmed that the removed tissue contains mesothelioma tumor sections.
- You have finished active cancer treatment and have been in follow-up (no active treatment) for at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
This early-phase study tests a treatment that uses a patient’s immune cells (dendritic cell therapy) combined with surgery for epithelioid mesothelioma. It aims to help the immune system better recognize and attack the cancer after chemotherapy and before/around surgery.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This trial studies how well pembrolizumab (an immune therapy) works when added to chemotherapy before image-guided surgery for malignant pleural mesothelioma. It aims to shrink or control the cancer and improve surgical results by combining treatments.
This study tests whether atezolizumab given after surgery and chemotherapy can lower the risk of mesothelioma coming back compared with a placebo. It may help by boosting the immune system to control remaining microscopic cancer cells.
Hear when a new Mesothelioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.